Pyxis Oncology (PYXS) Amortizatization of Intangibles (2023 - 2025)
Pyxis Oncology (PYXS) reported Amortizatization of Intangibles of $375000.0 for Q4 2025, down 75.54% year-over-year from $1.5 million in Q4 2024, and down 29.51% quarter-over-quarter from $532000.0 in Q3 2025.
Pyxis Oncology (PYXS) Amortizatization of Intangibles (2023 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 3 years of Amortizatization of Intangibles data on file, last reported at $375000.0 in Q4 2025.
- Amortizatization of Intangibles for Q4 2025 came in at $375000.0, down 75.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.0 million (down 51.55% YoY), and the FY2025 annual result was $3.0 million, down 51.55% from the prior year.
- Amortizatization of Intangibles declined to $375000.0 in Q4 2025 per PYXS's latest filing, from $532000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.7 million in Q3 2024 and troughed at $375000.0 in Q4 2025.
- A 3-year average of $1.2 million and a median of $1.3 million in 2023 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles soared 112.19% in 2024, then plunged 75.54% in 2025.
- A 3-year view of Amortizatization of Intangibles shows it stood at $1.4 million in 2023, then advanced by 6.38% to $1.5 million in 2024, then sank by 75.54% to $375000.0 in 2025.
- Business Quant data shows PYXS's Amortizatization of Intangibles at $375000.0 in Q4 2025, $532000.0 in Q3 2025, and $896000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Pyxis Oncology | 125.84 Mn | 108.95 Mn | 8.65 Mn | 375,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Jun 30, 2025 | 896,000.00 |
| Jun 30, 2025 | 896,000.00 |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.48 Mn |